|
Lipid 8
|
|
2226547-25-5
|
|
Enpp-1-IN-14
|
化合物ENPP-1-IN-14
|
2687222-59-7
|
|
Crisnatol
|
BWA770U
|
96389-68-3
|
|
EIF2α activator 2
|
化合物 EIF2Α ACTIVATOR 2
|
1501618-04-7
|
|
NS2B/NS3-IN-3
|
化合物 NS2B/NS3-IN-3
|
2832876-90-9
|
|
Biotin-aniline
|
生物素-苯胺
|
769933-15-5
|
|
TPE-MI
|
马来酰胺修饰的TPE
|
1245606-71-6
|
|
BV02
|
2-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID
|
292870-53-2
|
|
GNE-9278
|
4-环丙基-7-氟-3,4-二氢-2H-苯并[E][1,2,4]噻二嗪 1,1-二氧化物
|
1204572-55-3
|
|
BAY-4931
|
BAY-4931
|
423150-91-8
|
|
LP-261
|
LP-261
|
915412-67-8
|
|
Verapamil-d
|
N-(6-Nitrobenzo[d]thiazol-2-yl) cyclohexane carboxaMide
|
312747-21-0
|
|
ML266
|
2-(2-((4-bromophenyl)amino)-2-oxoethoxy)-N-(2-(methyl(phenyl)amino)-2-oxoethyl)benzamide
|
1462267-08-8
|
|
ThioLox
|
ThioLox
|
1202193-89-2
|
|
CRT0105950
|
CRT-0105950
(CRT0105950)
|
1661845-86-8
|
|
hENT4-IN-1
|
2,2'-[[4,8-Bis[bis(2-methylpropyl)amino]pyrimido[5,4-d]pyrimidine-2,6-diyl]diimino]bis-ethanol
|
949467-71-4
|
|
Arteannuin B
|
|
698346-43-9
|
|
Protein kinase inhibitor 1 hydrochloride
|
5-[[1,2-二氢-2-氧代-6'-(1-哌嗪基)[3,3'-联苯]-5-基]亚甲基]-2,4-噻唑烷二酮盐酸盐
|
2321337-71-5
|
|
SRI-41315
|
2-环丁基-10-甲基-3-苯基嘧啶并[4,5-B]喹啉-4,5(3H,10H)-二酮
|
1613509-49-1
|
|
Dynole 224
|
化合物 DYNOLE 2?24
|
1416313-72-8
|
|
Tucidinostat-d
|
化合物HDAC-IN-40
|
2463198-51-6
|
|
TP0472993
|
|
2126874-77-7
|
|
(-)-Sotalol
|
l-Sotalol
|
30236-31-8
|
|
GPR41 agonist-1
|
化合物 GPR41 AGONIST-1
|
506417-09-0
|
|
MAO-B-IN-8
|
化合物 MAO-B-IN-8
|
1638956-60-1
|
|
MSP-3
|
2-Thiophenebutanamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-
|
1820968-63-5
|
|
yGsy2p-IN-H23
|
|
1269190-98-8
|
|
Seclidemstat mesylate
|
SECLIDEMSTAT MESYLATE
|
2044953-70-8
|
|
Claficapavir
|
化合物 CLAFICAPAVIR
|
2055732-24-4
|
|
PA3552-IN-1
|
|
1008121-12-7
|
|
BAY-0069
|
BAY-0069
|
420826-65-9
|
|
Hsp90-IN-17 hydrochloride
|
|
1253584-63-2
|
|
FAK-IN-7
|
N-(5-(对甲苯基)-1,3,4-噻二唑-2-基)苯甲酰胺
|
19948-85-7
|
|
PND-1186 hydrochloride
|
CS-1120
|
1356154-94-3
|
|
DDX3-IN-2
|
化合物 DDX3-IN-2
|
1919828-81-1
|
|
FTO-IN-8
|
化合物 FTO-IN-8
|
2640366-38-5
|
|
PKM2 activator 2
|
化合物 PKM2 ACTIVATOR 2
|
1186660-06-9
|
|
Enpp/Carbonic anhydrase-IN-1
|
4-(金刚烷-1-甲酰胺基)苯基 苯磺酸酯
|
2883495-35-8
|
|
EAI001
|
2-(1-氧代异吲哚啉-2-基)-2-苯基-N-(噻唑-2-基)乙酰胺
|
892772-75-7
|
|
RA839
|
化合物 T28497
|
1832713-02-6
|
|
Dlin-MeOH
|
(6Z,9Z,28Z,31Z)-三十七烷-6,9,28,31-四烯-19-醇
|
1169768-28-8
|
|
GSK2879552 dihydrochloride
|
GSK2879552
|
1902123-72-1
|
|
SARS-CoV-2-IN-7
|
|
2570461-66-2
|
|
JG-231
|
化合物 CCT245232
|
1693731-14-4
|
|
MPO-IN-3
|
|
1435469-45-6
|
|
ALDH1A3-IN-1
|
化合物 ALDH1A3-IN-1
|
1695970-90-1
|
|
SARS-CoV-2-IN-13
|
化合物SARS-COV-2-IN-13
|
56961-10-5
|
|
Cathepsin X-IN-1
|
化合物CATHEPSIN X-IN-1
|
2418577-51-0
|
|
Andolast free base
|
4-(1H-tetrazol-5-yl)-N-(4-(1H-tetrazol-5-yl)phenyl)benzamide
|
132640-22-3
|
|
PERK-IN-4
|
1-[5-(4-AMino-7-Methyl-7H-pyrrolo[2,3-d]pyriMidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-fluoro-5-(trifluoroMethyl)phenyl]ethanone
|
1337531-89-1
|
|
L82
|
化合物 L82
|
329227-30-7
|
|
GRK2 Inhibitor 1
|
呋喃妥因-13C3
|
24269-96-3
|
|
KDM4C-IN-1
|
化合物 KDM4C-IN-1
|
52348-60-4
|
|
KKII5
|
4,6-二苯基-1,2,3,4-四氰嘧啶-2-硫
|
6381-55-1
|
|
HQ461
|
HQ461
|
1226443-41-9
|
|
C/EBPα inducer 1
|
化合物T8871
|
2374285-52-4
|
|
Acetaminophen glucuronide
|
奥西替尼杂质2
|
2227103-37-7
|
|
YSK 05
|
YSK05
|
1318793-78-0
|
|
ULK1-IN-2
|
化合物 ULK1-IN-2
|
2497409-01-3
|
|
Mevalonic acid lithium salt
|
MEVALONATE (LITHIUM SALT)
|
2618458-93-6
|
|
S116836
|
化合物KG5
|
877874-85-6
|
|
ASN03576800
|
ASN03576800
|
957513-35-8
|
|
AZT triphosphate TEA
|
3',4'-二甲氧基黄酮
|
4143-62-8
|
|
SW157765
|
3-(呋喃-2-基)-N-(2-(吡啶-4-基)苯并[D]恶唑-5-基)丙烯酰胺
|
332063-87-3
|
|
Mesendogen
|
化合物 T28020
|
864716-85-8
|
|
YZ129
|
YZ129
|
1643120-60-8
|
|
SCH 32615
|
SCH 32615
|
83861-02-3
|
|
INF4E
|
Benzenepropanoic acid, 2-chloro-b-hydroxy-a-methylene-, ethyl ester
|
88039-46-7
|
|
USP7-IN-8
|
化合物USP7-IN-8
|
2009273-60-1
|
|
SET2
|
SET 2
|
2313525-20-9
|
|
PD 151746
|
|
181765-30-0
|
|
NCT02
|
2-{5H,6H,7H-茚并[5,6-B]呋喃-3-基}-N-(5-甲基-1,3-噻唑-2-基)乙酰胺
|
790245-61-3
|
|
DP00477
|
|
169120-56-3
|
|
STL1267
|
|
1429024-58-7
|
|
CBB1007 trihydrochloride
|
|
2070015-03-9
|
|
LP-922056
|
LX5061
|
1365060-22-5
|
|
KCNQ2/3 activator-1
|
N-[4-(6-氟-3,4-二氢-2(1H)-异喹啉基)-2,6-二甲基苯基]-3,3-二甲基丁酰胺
|
1009344-33-5
|
|
ML291
|
ML291
|
1523437-16-2
|
|
dCeMM4
|
化合物 DCEMM4
|
1281683-44-0
|
|
BI-9627 hydrochloride
|
BIX HCl
|
1422252-46-7
|
|
TGP-377/421
|
化合物 TGP-377/421
|
16752-89-9
|
|
ML-SA5
|
N'-[3-氯-2-(1-哌啶基)苯基]-N,N-二甲基-1,4-苯二磺酰胺
|
2418670-70-7
|
|
SLF TFA
|
|
2378802-47-0
|
|
Almonertinib mesylate
|
阿美替尼甲磺酸盐
|
2134096-06-1
|
|
ALOX15-IN-2
|
|
2764818-23-5
|
|
Mtb ATP synthase-IN-1
|
化合物 MTB ATP SYNTHASE-IN-1
|
2642394-38-3
|
|
EM127
|
化合物 EM127
|
1886879-71-5
|
|
LDC4297 hydrochloride
|
|
2319747-14-1
|
|
EGFR-IN-51
|
2-(ACETYLOXY)-4-[(NITROOXY)METHYL]PHENYL ESTER, BENZOIC ACID
|
287118-97-2
|
|
NUCC-0000323
|
4-(5-((4-溴苄基)硫基)-4-甲基-4H-1,2,4-三唑-3-基)吡啶
|
663212-78-0
|
|
Valiloxibic acid
|
VALILOXIBIC ACID
|
238401-16-6
|
|
LDHA-IN-3
|
LDHA抑制剂3
|
227010-33-5
|
|
KDM2B-IN-2
|
化合物KDM2B-IN-2
|
1965248-01-4
|
|
(3S,4S)-PF-06459988
|
(3S,4S)-PF-06459988
|
1858291-14-1
|
|
Anti-inflammatory agent 35
|
化合物T64358
|
2293951-00-3
|
|
BRD7586
|
|
895460-70-5
|
|
USP8-IN-3
|
100MG
|
2477651-10-6
|
|
KWCN-41
|
|
2913223-17-1
|
|
Roflupram
|
1-Butanone, 1-[4-(difluoromethoxy)-3-[(tetrahydro-3-furanyl)oxy]phenyl]-3-methyl-
|
1093412-18-0
|
|
SRI-37240
|
化合物 SRI-37240
|
883956-47-6
|